Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Matteo Perrino"'
Autor:
Matteo Perrino, Emanuele Voulaz, Simone Balin, Gerardo Cazzato, Elena Fontana, Sara Franzese, Martina Defendi, Fabio De Vincenzo, Nadia Cordua, Roberto Tamma, Federica Borea, Marta Aliprandi, Marco Airoldi, Luigi Giovanni Cecchi, Roberta Fazio, Marco Alloisio, Giuseppe Marulli, Armando Santoro, Luca Di Tommaso, Giuseppe Ingravallo, Laura Russo, Giorgio Da Rin, Anna Villa, Silvia Della Bella, Paolo Andrea Zucali, Domenico Mavilio
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Thymic epithelial tumors (TETs) are rare mediastinal cancers originating from the thymus, classified in two main histotypes: thymoma and thymic carcinoma (TC). TETs affect a primary lymphoid organ playing a critical role in keeping T-cell homeostasis
Externí odkaz:
https://doaj.org/article/82ca357fe64d44e2bab8ed8d76fd1bce
Autor:
Matteo Perrino, Nadia Cordua, Fabio De Vincenzo, Federica Borea, Marta Aliprandi, Luigi Giovanni Cecchi, Roberta Fazio, Marco Airoldi, Armando Santoro, Paolo Andrea Zucali
Publikováno v:
Cancers, Vol 15, Iss 23, p 5574 (2023)
Thymic epithelial tumors (TETs) comprise a rare group of thoracic cancers, classified as thymomas and thymic carcinomas (TC). To date, chemotherapy is still the standard treatment for advanced disease. Unfortunately, few therapeutic options are avail
Externí odkaz:
https://doaj.org/article/e3e7d007100e4c2b9a9b394f80bdb259
Autor:
Matteo Perrino, Fabio De Vincenzo, Nadia Cordua, Federica Borea, Marta Aliprandi, Armando Santoro, Paolo Andrea Zucali
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Malignant mesothelioma (MM) is a rare and aggressive neoplasm, usually associated with a poor prognosis (5 years survival rate
Externí odkaz:
https://doaj.org/article/d6a5f8003588425cb4adb8069ab9a417
Autor:
Federica Borea, Marika A. Franczak, Maria Garcia, Matteo Perrino, Nadia Cordua, Ryszard T. Smolenski, Godefridus J. Peters, Rafal Dziadziuszko, Armando Santoro, Paolo A. Zucali, Elisa Giovannetti
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 11, p 9165 (2023)
Malignant Pleural Mesothelioma (MPM) is a rare neoplasm that is typically diagnosed in a locally advanced stage, making it not eligible for radical surgery and requiring systemic treatment. Chemotherapy with platinum compounds and pemetrexed has been
Externí odkaz:
https://doaj.org/article/712cc6ebcac34bc987933e89f02b71e4
Autor:
Rosanna Asselta, Luca Di Tommaso, Matteo Perrino, Annarita Destro, Laura Giordano, Giulia Cardamone, Luca Rubino, Armando Santoro, Stefano Duga, Paolo Andrea Zucali
Publikováno v:
Thoracic Cancer, Vol 12, Iss 9, Pp 1271-1278 (2021)
Abstract Background Significant efforts have been made to investigate the molecular pathways involved in thymic carcinogenesis. However, genetic findings have still not impacted clinical practice. The aim of this exploratory trial was to evaluate the
Externí odkaz:
https://doaj.org/article/c2022b72fe96420191f30f8582e0a660
Autor:
Rui Wang, Antoine Italiano, Shubham Pant, Johann De Bono, Todd M Bauer, Christophe Massard, Chia-Chi Lin, Roberto Iacovelli, Martin Gutierrez, Mansoor Saleh, Helen Lee, Gennaro Daniele, Paolo Andrea Zucali, Marielle Chiron, Bradley C Carthon, Robin Meng, Giovanni Abbadessa, Marcello Tucci, Wu-Chou Su, Alastair Greystoke, Ying-Chun Shen, Matteo Perrino, Yingwen Dong, Laure Loumagne, Lucie Lépine
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 1 (2022)
Externí odkaz:
https://doaj.org/article/77a4d7bd1ff24db7bd8825f9ede35742
Autor:
Camilla De Carlo, Marina Valeri, Noemi Rudini, Paolo Andrea Zucali, Miriam Cieri, Grazia Maria Elefante, Federica D’antonio, Rodolfo Hurle, Laura Giordano, Alessandra Bressan, Massimo Lazzeri, Matteo Perrino, Giorgio Guazzoni, Luigi Maria Terracciano, Piergiuseppe Colombo
Publikováno v:
Cancers, Vol 14, Iss 13, p 3256 (2022)
In recent years, immunohistochemical protein expression was studied as a surrogate to the molecular classification of bladder cancer, although no tissue biomarkers are available for clinical use to predict survival or the response to neoadjuvant chem
Externí odkaz:
https://doaj.org/article/c579ac5a56fd41188da86cdc0e1f5ea2
Autor:
Sara Elena Rebuzzi, Alessio Signori, Giuseppe Luigi Banna, Marco Maruzzo, Ugo De Giorgi, Paolo Pedrazzoli, Andrea Sbrana, Paolo Andrea Zucali, Cristina Masini, Emanuele Naglieri, Giuseppe Procopio, Sara Merler, Laura Tomasello, Lucia Fratino, Cinzia Baldessari, Riccardo Ricotta, Stefano Panni, Veronica Mollica, Mariella Sorarù, Matteo Santoni, Alessio Cortellini, Veronica Prati, Hector Josè Soto Parra, Marco Stellato, Francesco Atzori, Sandro Pignata, Carlo Messina, Marco Messina, Franco Morelli, Giuseppe Prati, Franco Nolè, Francesca Vignani, Alessia Cavo, Giandomenico Roviello, Francesco Pierantoni, Chiara Casadei, Melissa Bersanelli, Silvia Chiellino, Federico Paolieri, Matteo Perrino, Matteo Brunelli, Roberto Iacovelli, Camillo Porta, Sebastiano Buti, Giuseppe Fornarini
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Background: Despite the survival advantage, not all metastatic renal cell carcinoma (mRCC) patients achieve a long-term benefit from immunotherapy. Moreover, the identification of prognostic biomarkers is still an unmet clinical need. Methods: This m
Externí odkaz:
https://doaj.org/article/b7fbd6a0e95e4fbc8e3f9aaff8b8f0d2
Autor:
Paolo Andrea Zucali, Nadia Cordua, Federica D'Antonio, Federica Borea, Matteo Perrino, Fabio De Vincenzo, Armando Santoro
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Patients with muscle-infiltrating bladder cancer (MIBC) present a high risk of postoperative recurrence and death from metastatic urothelial cancer despite surgical resection. Before the use of peri-operative chemotherapy, about half (52%) of patient
Externí odkaz:
https://doaj.org/article/6e426517b80842318dd282b86332d017
Autor:
Luca Toschi, Giovanna Finocchiaro, Teresa T Nguyen, Margaret C Skokan, Laura Giordano, Letizia Gianoncelli, Matteo Perrino, Licia Siracusano, Luca Di Tommaso, Maurizio Infante, Marco Alloisio, Massimo Roncalli, Marta Scorsetti, Pasi A Jänne, Armando Santoro, Marileila Varella-Garcia
Publikováno v:
PLoS ONE, Vol 9, Iss 4, p e95303 (2014)
We aimed to investigate prevalence and prognostic role of SOX2, PIK3CA, FGFR1 and BRF2 gene gain in patients with surgically resected non-small cell lung cancer (NSCLC).SOX2, PIK3CA, FGFR1 and BRF2 gene copy number was assessed by fluorescence in sit
Externí odkaz:
https://doaj.org/article/86e67c9e69fc44cf9f507eb57c679453